
At the interim analysis, the mRNA-1273 vaccine was found to have an efficacy of 94.5% against confirmed COVID-19.

At the interim analysis, the mRNA-1273 vaccine was found to have an efficacy of 94.5% against confirmed COVID-19.

Host genetic variants associated with critical illness may identify mechanistic targets for therapeutic development.

UV light-emitting diodes are an emerging technology and a UV source for pathogen inactivation.

Data from three ongoing clinical studies were included in the EUA request.

Investigators are calling for routine use of these tests for patients admitted with acute respiratory symptoms during the influenza season.

As Covid-19 infections soar across the U.S., states are again tightening restrictions and reinstituting lock down measures.

The virus is known to invade human cells through the ACE2 receptor-driven pathway, primarily impacting the respiratory tract.

While the number of study participants was too small to extrapolate for the whole population, the authors said they were encouraged.

Response to the COVID-19 pandemic has been hindered by lack of an effective antiviral therapy.

The U.S. sentinel surveillance program is a project which monitors for antibiotic-resistant gonorrhea.

The findings are consistent with the hypothesis that bats are the viral origin and reservoir species.

A large family of viruses, coronaviruses include common cold viruses as well as more severe viruses.

Detection of SARS-CoV-2 relies predominantly on nucleic acid testing and serological testing.

Mutations in TMEM41B are known to be common in one in five East Asians, but not in Europeans or Africans.

New data sheds light on efficacy of longer periods between dosing.

Many ocular symptoms are associated with the term ‘conjunctivitis’ which may be misleading.

Even as knowledge about SARS-COV-2 has considerably improved, several aspects remain unknown.

The announcement follows Pfizer and Moderna who both showed their vaccines to be over 90% efficacious.

TMA mediated by the complement cascade has been identified as a potential cause for severe manifestations of COVID-19 in adults.

An overall COVID-19 mortality rate of more than 5% for those admitted to a hospital highlights the urgent need for treatments.

A large-scale diagnosis of SARS-CoV-2 is paramount to downregulating its spread and mitigating the current outbreak.

The primary outcome was to determine how many cases of symptomatic COVID-19 disease there were in participants who had received two doses of the vaccine.

The need for rapid, widespread, accurate testing has motivated research exploring new potential strategies.

Investigators identify gene expression which may explain the highly transmissible nature of the virus.

The study was posted to the website clinicaltrials.gov this past Wednesday.

WHO has recently recommended using assessment for monitoring of clinical deterioration in patients with COVID-19.

Previous studies with influenza in animals demonstrated antiviral efficacy was not species restricted.

Physicians are beginning to find key patterns which will aid public health in the future.

Experts call for wide roll-out across West and Central Africa.

Further investigation has to be conducted before this method can be used in human patients.